Your browser is no longer supported. Please, upgrade your browser.
RMD ResMed Inc. daily Stock Chart
ResMed Inc.
IndexS&P 500 P/E30.25 EPS (ttm)2.40 Insider Own0.60% Shs Outstand142.33M Perf Week-1.92%
Market Cap10.35B Forward P/E21.68 EPS next Y3.35 Insider Trans-27.24% Shs Float140.77M Perf Month-6.22%
Income342.30M PEG2.99 EPS next Q0.66 Inst Own63.30% Short Float6.20% Perf Quarter7.45%
Sales2.07B P/S5.01 EPS this Y-3.50% Inst Trans-0.09% Short Ratio6.98 Perf Half Y1.39%
Book/sh13.84 P/B5.25 EPS next Y10.77% ROA10.10% Target Price69.91 Perf Year5.23%
Cash/sh5.77 P/C12.59 EPS next 5Y10.13% ROE18.80% 52W Range56.59 - 79.63 Perf YTD17.16%
Dividend1.40 P/FCF47.36 EPS past 5Y7.10% ROI11.40% 52W High-8.70% Beta0.82
Dividend %1.93% Quick Ratio3.80 Sales past 5Y8.60% Gross Margin58.10% 52W Low28.47% ATR1.28
Employees6080 Current Ratio4.60 Sales Q/Q7.30% Oper. Margin20.60% RSI (14)35.73 Volatility1.15% 1.59%
OptionableYes Debt/Eq0.55 EPS Q/Q8.60% Profit Margin16.60% Rel Volume0.37 Prev Close72.44
ShortableYes LT Debt/Eq0.55 EarningsAug 01 AMC Payout54.50% Avg Volume1.25M Price72.70
Recom3.00 SMA20-3.77% SMA50-4.52% SMA2005.38% Volume467,971 Change0.36%
Aug-02-17Upgrade Citigroup Neutral → Buy
Aug-02-17Downgrade Credit Suisse Outperform → Neutral
Aug-02-17Downgrade BofA/Merrill Buy → Neutral
Apr-28-17Downgrade Citigroup Buy → Neutral
Jan-24-17Upgrade JP Morgan Neutral → Overweight
Jan-24-17Reiterated Canaccord Genuity Hold $55 → $59
Oct-04-16Initiated JP Morgan Neutral $64
Aug-23-16Downgrade Jefferies Hold → Underperform
Jun-27-16Downgrade Needham Hold → Underperform
Apr-28-16Upgrade Macquarie Underperform → Neutral
Apr-27-16Downgrade Piper Jaffray Overweight → Neutral
Apr-07-16Resumed Barclays Underweight $55
Jan-22-16Upgrade Credit Suisse Neutral → Outperform
Jan-19-16Downgrade Barclays Equal Weight → Underweight $61 → $52
Dec-17-15Downgrade Needham Buy → Hold
Jul-13-15Downgrade Macquarie Neutral → Underperform
Jun-25-15Initiated Barclays Equal Weight $61
May-14-15Reiterated Needham Buy $77 → $65
May-13-15Downgrade BofA/Merrill Buy → Neutral
Apr-27-15Downgrade Goldman Buy → Neutral
Aug-16-17 08:00AM  3 Dividend Healthcare Stocks Motley Fool
07:10AM  Earnings Review and Free Research Report: ResMed Adjusted Diluted EPS Increased 4% ACCESSWIRE
Aug-14-17 08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Aug-12-17 11:25PM  Edited Transcript of RMD earnings conference call or presentation 1-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
08:05AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Aug-11-17 07:10AM  Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators ACCESSWIRE
Aug-07-17 02:57PM  ResMed, Inc. :RMD-US: Earnings Analysis: 2017 By the Numbers : August 7, 2017 Capital Cube
Aug-03-17 09:52AM  ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : August 3, 2017 Capital Cube
09:01AM  ResMed Tops Expectations but Falls Anyway Motley Fool
Aug-02-17 09:39AM  ResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track Zacks -6.41%
Aug-01-17 09:55PM  ResMed beats 4Q profit forecasts Associated Press
04:05PM  ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2017 PR Newswire
Jul-31-17 10:19AM  Medical Products Earnings Due on Aug 1: IDXX, RMD Zacks
Jul-21-17 09:21AM  Is a Surprise in Store for ResMed (RMD) in Q4 Earnings? Zacks
Jul-19-17 05:49PM  MGM Resorts, ResMed, Packaging Corporation of America, A.O. Smith and Duke Realty Set to Join S&P 500; Others to Join S&P MidCap 400 PR Newswire
Jul-12-17 10:20AM  Here's Why You Should Add ResMed to Your Portfolio Now Zacks
Jul-07-17 09:15AM  ResMed Sees Potential in SDB Market, Eyes Global Growth Zacks
Jul-06-17 05:30PM  Top Leadership of ViaSat, ResMed, Qualcomm, DLA Piper join EvoNexus Board of Directors PR Newswire
Jun-29-17 04:05PM  ResMed to Announce Fourth Quarter Fiscal Year 2017 Results PR Newswire
Jun-20-17 09:28AM  ResMed (RMD) at 52-Week High: What's Driving the Stock? Zacks
Jun-14-17 02:26PM  Which Stocks Are Showing Rising Relative Strength? Investor's Business Daily
11:53AM  Sleep Apnea Treatment Provider Enters New Buy Zone Investor's Business Daily
Jun-09-17 03:35PM  FDA Approval Boosts Baxters Generic Injectable Business Market Realist
May-31-17 04:12AM  Why Is ResMed (RMD) Down 3.8% Since the Last Earnings Report? Zacks
May-25-17 12:47PM  ETFs with exposure to ResMed, Inc. : May 25, 2017 Capital Cube
May-22-17 09:15AM  Big Data Yields Big Insights for Treatment of Central Sleep Apnea PR Newswire
May-21-17 10:04AM  Clinical Trial Published in JAMA Offers New Hope for COPD Patients PR Newswire
May-17-17 04:22AM  Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel PR Newswire
May-16-17 08:13PM  ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare Reuters
09:00AM  Introducing the Softest CPAP Mask from ResMed PR Newswire
May-08-17 09:01PM  Edited Transcript of RMD earnings conference call or presentation 27-Apr-17 8:30pm GMT Thomson Reuters StreetEvents
May-04-17 09:30AM  Why Motley Fool Co-Founder David Gardner Likes ResMed Inc. Motley Fool
May-02-17 04:33PM  ETFs with exposure to ResMed, Inc. : May 2, 2017 Capital Cube
May-01-17 10:44AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q3, 2017 By the Numbers : May 1, 2017 Capital Cube
09:04AM  Acquisitions Help Drive ResMed's Revenue 13% Higher Motley Fool
Apr-28-17 05:11PM  ResMed, Inc. Value Analysis (NYSE:RMD) : April 28, 2017 Capital Cube -6.67%
10:55AM  ResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates Zacks
Apr-27-17 06:02PM  ResMed tops 3Q profit forecasts Associated Press
04:05PM  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2017 PR Newswire
08:35AM  ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : April 27, 2017 Capital Cube
Apr-26-17 08:19AM  Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More Zacks
Apr-25-17 09:39AM  ResMed Unveils AirMini - the World's Smallest CPAP PR Newswire
09:19AM  ResMed Unveils AirMini - the World's Smallest CPAP CNW Group
Apr-18-17 09:27AM  ResMed (RMD) Q3 Earnings: Disappointment in the Cards? Zacks
Apr-11-17 04:17PM  ResMed's Study Results for Central Sleep Apnea Hold Promise Zacks
Apr-07-17 05:24PM  ETFs with exposure to ResMed, Inc. : April 7, 2017 Capital Cube
Apr-06-17 09:00AM  New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea PR Newswire
Apr-05-17 08:24AM  ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : April 5, 2017 Capital Cube
Mar-30-17 04:05PM  ResMed to Announce Third Quarter Fiscal Year 2017 Results PR Newswire
Mar-27-17 08:12AM  Align Partners Zfx GmbH to Expand iTero Scanner Business Zacks
08:09AM  VWR Corp Acquires EPL Archives, Improves Customer Service Zacks
Mar-24-17 12:27PM  PetMed Express' New Order Sales Disappoint, Competition Rife Zacks
09:30AM  Zacks Industry Outlook Highlights: Quidel, OraSure Technologies, ResMed, Inogen and Masimo
09:04AM  Walgreen Boots Buyout of Rite Aid Delayed, Other Woes Remain Zacks
Mar-23-17 04:17PM  Medtronic's (MDT) CoreValve Evolut Pro Receives FDA Approval Zacks
08:48AM  Hologic Completes Cynosure Buyout, Boosts Core Business Zacks
Mar-22-17 09:29AM  Align's iTero Hits 1 Billion Mark, Boosts Scanner Business Zacks
09:11AM  Genomic Health's Cancer Test Business Strong, Expenses High
09:00AM  Brightree Expands Sleep Therapy Capabilities with ResMeds AirView Platform Business Wire
Mar-21-17 10:58AM  Integer (ITGR) Amends Term B Loan to Lower Interest Rate
08:34AM  Genomic Health's Breast Recurrence Test Data Encouraging
Mar-20-17 06:05PM  Research on Treating Sleep Apnea with Adaptive Servo-ventilation Published in the Journal of the American College of Cardiology (JACC) PR Newswire
09:40AM  Medtronic's Positive 2-Year SURTAVI Data Boosts Corevalve
09:14AM  Abbott Laboratories' MitraClip Outcome Positive for DMR
Mar-17-17 04:05PM  Thermo Fisher Poised on Innovation, Global Growth Amid Woes
09:18AM  CVS Health Launches Reduced Rx for Affordable Medication
Mar-16-17 09:34AM  Align Technology Hits a 52-Week High on Solid Prospects
Feb-25-17 09:34AM  3 Healthcare Stocks to Invest In at Motley Fool
Feb-23-17 04:35AM  ResMed (RMD) Up 3.6% Since Earnings Report: Can It Continue?
Feb-13-17 09:00AM  ResMed Named Global Leader in Remote Patient Monitoring PR Newswire
Jan-30-17 08:15AM  Post Earnings Coverage as ResMed Revenue Increased 17% Accesswire
Jan-28-17 01:04PM  RESMED INC Financials
Jan-25-17 01:30PM  ETFs with exposure to ResMed, Inc. : January 25, 2017
08:43AM  ResMed's Revenue Jumps, but Higher Costs Keep Profits in Check at Motley Fool
06:27AM  Here's Why This Rally Is Sustainable: Cramer's 'Mad Money' Recap (Tuesday 1/24/17)
06:23AM  ResMed: Cramer's Top Takeaways
06:05AM  RESMED INC Files SEC form 10-Q, Quarterly Report
Jan-24-17 07:25PM  Cramer Remix: The best way to play the oil patch at CNBC +9.62%
04:32PM  ResMed stock surges after strong quarterly results at CNBC
04:27PM  Breaking Out: ResMed Stock Launches As Fiscal Q2 Sales, EPS Beat
03:08PM  ResMed Reports Q2 Profit of $76.7M (RMD) at Investopedia
12:48PM  Why ResMed Is in the Green Today at Motley Fool
10:57AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q2, 2017 By the Numbers : January 24, 2017
09:04AM  Morning Movers: Lockheed Martin Tumbles, Johnson & Johnson Slips, AK Steel Soars at
08:12AM  ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
07:49AM  ResMed upgraded by JP Morgan
01:09AM  BlueScope, ResMed news boosts share market Other
Jan-23-17 08:43PM  ResMed Q2 profit down but revenue up Other
08:42PM  Edited Transcript of RMD earnings conference call or presentation 23-Jan-17 9:30pm GMT
06:04PM  After hours buzz: YHOO, RMD, MRCY at CNBC
04:14PM  ResMed tops Street 2Q forecasts AP
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017 PR Newswire
07:07AM  Q2 2017 ResMed Inc Earnings Release - 4:00 pm ET
Jan-20-17 05:28PM  ResMed and BMC/3B Medical Settle Global Litigation PR Newswire
08:14AM  Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD Other
Jan-13-17 06:37AM  ResMed (RMD) Q2 Earnings: Disappointment in the Cards? Zacks
Jan-12-17 04:26PM  RESMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
03:00AM  ResMed's myAir Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea PR Newswire
Jan-11-17 07:27AM  Why a Massive Short Squeeze Could Send These 4 Stocks Into Orbit at TheStreet
ResMed Inc. designs, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SULPIZIO RICHARDDirectorAug 09Option Exercise33.7024,390821,94328,819Aug 11 02:33 PM
SULPIZIO RICHARDDirectorAug 09Sale73.8524,3901,801,2024,429Aug 11 02:33 PM
FARRELL PETER CDirectorAug 04Option Exercise27.5820,000551,600321,557Aug 07 05:25 PM
FARRELL PETER CDirectorAug 04Sale75.1520,0001,503,000301,557Aug 07 05:25 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Option Exercise27.586,364175,51984,476Aug 04 04:08 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Sale72.106,364458,84478,112Aug 04 04:08 PM
Sandercock BrettChief Financial OfficerAug 01Sale77.491,25096,86359,258Aug 01 09:16 PM
Hollingshead JamesPresident, AmericasJul 14Option Exercise43.635,265229,71243,358Jul 17 01:59 PM
Hollingshead JamesPresident, AmericasJul 14Sale77.437,140552,85036,218Jul 17 01:59 PM
FARRELL PETER CDirectorJul 05Option Exercise27.5820,000551,600321,557Jul 06 06:13 PM
FARRELL PETER CDirectorJul 05Sale76.5020,0001,530,064301,557Jul 06 06:13 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Option Exercise27.586,364175,51984,476Jul 05 03:04 PM
Sandercock BrettChief Financial OfficerJul 03Sale77.441,25096,80060,508Jul 05 06:56 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Sale77.366,364492,31978,112Jul 05 03:04 PM
SULPIZIO RICHARDDirectorJun 22Sale77.8265,8875,127,2600Jun 27 07:34 PM
PACE GARY WDirectorJun 15Option Exercise33.7022,660763,642120,247Jun 16 11:20 AM
PACE GARY WDirectorJun 15Sale76.0022,6601,722,16097,587Jun 16 11:20 AM
PACE GARY WDirectorJun 14Option Exercise33.701,73058,30199,317Jun 16 11:20 AM
PACE GARY WDirectorJun 14Sale76.001,730131,48097,587Jun 16 11:20 AM
PENDARVIS DAVIDChief Administrative OfficerJun 05Option Exercise27.586,365175,54784,477Jun 06 02:11 PM
FARRELL PETER CDirectorJun 05Option Exercise27.5820,000551,600321,557Jun 06 02:44 PM
PENDARVIS DAVIDChief Administrative OfficerJun 05Sale72.626,365462,22678,112Jun 06 02:11 PM
FARRELL PETER CDirectorJun 05Sale72.6520,0001,452,960301,557Jun 06 02:44 PM
Sandercock BrettChief Financial OfficerJun 01Sale71.021,25088,77561,758Jun 05 01:12 PM
FARRELL PETER CDirectorMay 04Option Exercise27.5820,000551,600321,557May 05 12:38 PM
FARRELL PETER CDirectorMay 04Sale68.7520,0001,374,920301,557May 05 12:38 PM
PENDARVIS DAVIDChief Administrative OfficerMay 03Option Exercise27.586,365175,54784,261May 05 11:58 AM
PENDARVIS DAVIDChief Administrative OfficerMay 03Sale69.556,365442,67977,896May 05 11:58 AM
Sandercock BrettChief Financial OfficerMay 01Sale68.601,25085,75062,783May 03 01:25 PM
ROBERTS CHRISTOPHER GDirectorApr 24Option Exercise30.4152,7931,605,298198,403Apr 25 07:16 PM
Hollingshead JamesPresident, AmericasApr 17Option Exercise43.635,264229,66844,934Apr 18 02:55 PM
Hollingshead JamesPresident, AmericasApr 17Sale68.377,139488,09337,795Apr 18 02:55 PM
FARRELL PETER CDirectorApr 04Option Exercise27.5820,000551,600321,557Apr 06 01:14 PM
FARRELL PETER CDirectorApr 04Sale70.6720,0001,413,360301,557Apr 06 01:14 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Option Exercise27.586,365175,54784,261Apr 04 05:58 PM
Sandercock BrettChief Financial OfficerApr 03Sale71.651,25089,56364,033Apr 04 07:52 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Sale71.596,365455,64577,896Apr 04 05:58 PM
FARRELL PETER CDirectorMar 06Option Exercise32.5020,000650,040321,557Mar 08 03:51 PM
FARRELL PETER CDirectorMar 06Sale71.7020,0001,434,000301,557Mar 08 03:51 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Option Exercise27.586,365175,54784,261Mar 06 04:02 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Sale72.226,365459,68077,896Mar 06 04:02 PM
Sandercock BrettChief Financial OfficerMar 01Sale72.481,25090,60065,283Mar 02 09:57 PM
ROBERTS CHRISTOPHER GDirectorFeb 22Sale72.1015,0001,081,500298,900Feb 24 03:22 PM
ROBERTS CHRISTOPHER GDirectorFeb 20Sale71.9110,000719,100313,900Feb 21 02:11 PM
FARRELL PETER CDirectorFeb 06Option Exercise33.7020,000674,000321,557Feb 07 03:14 PM
FARRELL PETER CDirectorFeb 06Sale68.3220,0001,366,420301,557Feb 07 03:14 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Option Exercise27.586,365175,54784,261Feb 06 03:22 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Sale67.166,365427,47377,896Feb 06 03:22 PM
Hollingshead JamesPresident, AmericasJan 17Option Exercise43.635,264229,66846,754Jan 19 05:22 PM
Hollingshead JamesPresident, AmericasJan 17Sale64.447,084456,49339,670Jan 19 05:22 PM
FARRELL PETER CDirectorJan 04Option Exercise33.7020,000674,000321,557Jan 05 05:24 PM
FARRELL PETER CDirectorJan 04Sale62.1420,0001,242,760301,557Jan 05 05:24 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Option Exercise27.586,365175,54784,261Jan 04 04:01 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Sale61.956,365394,31277,896Jan 04 04:01 PM
FARRELL PETER CDirectorDec 05Option Exercise33.7020,000674,000372,407Dec 06 04:49 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Option Exercise27.586,365175,54784,261Dec 06 04:50 PM
FARRELL PETER CDirectorDec 05Sale59.8320,0001,196,540352,407Dec 06 04:49 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Sale60.006,365381,90077,896Dec 06 04:50 PM
FARRELL PETER CDirectorNov 04Option Exercise33.7020,000674,000367,978Nov 07 02:16 PM
FARRELL PETER CDirectorNov 04Sale57.2820,0001,145,560347,978Nov 07 02:16 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Option Exercise33.706,033203,31287,306Nov 07 11:40 AM
PENDARVIS DAVIDChief Administrative OfficerNov 03Sale57.796,033348,64781,273Nov 07 11:40 AM
ROBERTS CHRISTOPHER GDirectorOct 19Option Exercise25.5436,000919,440145,610Oct 24 12:27 PM
Hollingshead JamesPresident, AmericasOct 18Sale64.711,967127,28545,513Oct 19 08:09 PM
Hollingshead JamesPresident, AmericasOct 17Option Exercise43.635,264229,66852,744Oct 18 08:13 PM
Farrell Michael J.Chief Executive OfficerOct 17Option Exercise33.705,975201,358203,781Oct 18 03:49 PM
Hollingshead JamesPresident, AmericasOct 17Sale64.435,264339,16047,480Oct 18 08:13 PM
Farrell Michael J.Chief Executive OfficerOct 17Sale64.255,975383,870197,806Oct 18 03:49 PM
FARRELL PETER CDirectorOct 04Option Exercise27.1420,000542,746367,978Oct 06 03:59 PM
FARRELL PETER CDirectorOct 04Sale64.7020,0001,293,960347,978Oct 06 03:59 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Option Exercise33.706,000202,20087,061Oct 04 05:30 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Sale63.956,000383,71881,061Oct 04 05:30 PM
Farrell Michael J.Chief Executive OfficerSep 15Option Exercise33.705,975201,358203,781Sep 16 09:15 PM
Farrell Michael J.Chief Executive OfficerSep 15Sale64.845,975387,419197,806Sep 16 09:15 PM
PENDARVIS DAVIDChief Administrative OfficerSep 06Option Exercise33.706,000202,20087,061Sep 08 12:43 PM
FARRELL PETER CDirectorSep 06Option Exercise25.5420,000510,800367,978Sep 08 12:44 PM
FARRELL PETER CDirectorSep 06Sale67.2920,0001,345,760347,978Sep 08 12:44 PM
PENDARVIS DAVIDChief Administrative OfficerSep 06Sale67.186,000403,05081,061Sep 08 12:43 PM
PACE GARY WDirectorAug 19Option Exercise25.5436,000919,440129,158Aug 22 06:18 PM
PACE GARY WDirectorAug 19Sale69.9336,0002,517,33693,158Aug 22 06:18 PM